Please login to the form below

Not currently logged in
Email:
Password:

Foundation Medicine

This page shows the latest Foundation Medicine news and features for those working in and with pharma, biotech and healthcare.

Roche agrees $2.4bn takeover of genomics player Foundation

Roche agrees $2.4bn takeover of genomics player Foundation

Offers a 29% premium on the Foundation’s recent share price. Three years after taking a $1bn stake in Foundation Medicine, Roche has decided it wants to take complete control of ... The price is a 29% premium on Foundation’s June 18 share price and

Latest news

More from news
Approximately 2 fully matching, plus 11 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Biogen Idec appoints senior neuroscientists Biogen Idec appoints senior neuroscientists

    Dr Henderson was most recently Gurewitsch and Vidda Foundation professor of Rehabilitation and Regenerative Medicine at Columbia University in New York City. ... He was also professor of Molecular Medicine at the Lerner College of Medicine at Case

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Mastering the precision medicine opportunity

    However, in precision medicine, we ask what treatment is best for the patient? ... This sets out a clear need for treatment agnostic broad panel testing that provides physicians with a decision support mechanism.  Foundation Medicine  has risen to this

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics